|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
|
US6946117B1
(en)
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
CA2327685C
(en)
*
|
1998-04-03 |
2008-11-18 |
Bm Research A/S |
Controlled release composition
|
|
US7022683B1
(en)
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
|
US6916490B1
(en)
|
1998-07-23 |
2005-07-12 |
UAB Research Center |
Controlled release of bioactive substances
|
|
AU5006999A
(en)
*
|
1998-07-23 |
2000-02-14 |
Johns Hopkins University School Of Medicine, The |
Controlled release of bioactive substances
|
|
ATE258777T1
(de)
*
|
1999-07-02 |
2004-02-15 |
Cognis Iberia Sl |
Mikrokapseln - ii
|
|
GB9924797D0
(en)
*
|
1999-10-20 |
1999-12-22 |
West Pharm Serv Drug Res Ltd |
Compound
|
|
US20030206958A1
(en)
*
|
2000-12-22 |
2003-11-06 |
Cattaneo Maurizio V. |
Chitosan biopolymer for the topical delivery of active agents
|
|
GB0008411D0
(en)
*
|
2000-04-05 |
2000-05-24 |
Vectura Ltd |
Pharmaceutical preparations and their manufacture
|
|
CA2382133C
(en)
|
2000-05-10 |
2010-11-23 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
US7527807B2
(en)
*
|
2000-06-21 |
2009-05-05 |
Cubist Pharmaceuticals, Inc. |
Compositions and methods for increasing the oral absorption of antimicrobials
|
|
CA2413251C
(en)
*
|
2000-06-21 |
2012-06-12 |
Cubist Pharmaceuticals, Inc. |
Compositions and methods to improve the oral absorption of antimicrobial agents
|
|
IT1318618B1
(it)
*
|
2000-07-10 |
2003-08-27 |
A C R Applied Coating Res S A |
Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
|
|
ITMI20010347A1
(it)
|
2001-02-21 |
2002-08-21 |
Grisotech S A |
Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale
|
|
US6777000B2
(en)
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
|
US7494669B2
(en)
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
|
JP2005501845A
(ja)
|
2001-08-16 |
2005-01-20 |
メディカル リサーチ カウンシル |
キチン微小粒子およびそれらの医学的用途
|
|
EP1443944A1
(de)
*
|
2001-11-12 |
2004-08-11 |
Johannes Reinmüller |
Pharmazeutische anwendungen von hyaluronsäure-präparaten
|
|
WO2003053411A1
(en)
|
2001-12-19 |
2003-07-03 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
|
US6830556B2
(en)
|
2002-01-08 |
2004-12-14 |
Zimmer Orthopaedic Surgical Products, Inc. |
Debridement extension providing irrigation and mechanical scrubbing for removal of dead, devitalized, or contaminated tissue from a wound
|
|
WO2003059848A2
(en)
*
|
2002-01-10 |
2003-07-24 |
Northeastern University |
Hybrid immobilized catalytic system with controlled permeability
|
|
US7638138B2
(en)
|
2003-02-21 |
2009-12-29 |
Translational Research, Ltd. |
Compositions for nasal administration of pharmaceuticals
|
|
MXPA05010379A
(es)
|
2003-03-27 |
2006-05-31 |
Bioactis Ltd |
Aparato para administrar una medicina en polvo en la cavidad intranasal.
|
|
US8383158B2
(en)
|
2003-04-15 |
2013-02-26 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
AU2004235744A1
(en)
*
|
2003-05-01 |
2004-11-18 |
Archimedes Development Limited |
Nasal administration of the LH-RH analog leuprolide
|
|
CN100381110C
(zh)
*
|
2003-06-16 |
2008-04-16 |
洛马林达大学医学中心 |
可展开的止血剂
|
|
WO2005002510A2
(en)
*
|
2003-06-16 |
2005-01-13 |
Loma Linda University Medical Center |
Deployable multifunctional hemostatic agent
|
|
US20050118238A1
(en)
*
|
2003-06-16 |
2005-06-02 |
Zhu Yong H. |
Deployable hemostatic agent
|
|
GB0315632D0
(en)
|
2003-07-04 |
2003-08-13 |
West Pharm Serv Drug Res Ltd |
Pharmaceutical formulations
|
|
DE10332160A1
(de)
*
|
2003-07-15 |
2005-02-03 |
Röhm GmbH & Co. KG |
Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
|
|
GB0328186D0
(en)
|
2003-12-05 |
2004-01-07 |
West Pharm Serv Drug Res Ltd |
Intranasal compositions
|
|
GB0329918D0
(en)
|
2003-12-24 |
2004-01-28 |
West Pharm Serv Drug Res Ltd |
Intranasal compositions
|
|
US20050175679A1
(en)
*
|
2004-02-10 |
2005-08-11 |
Michael Moshman |
Controlled release formulations
|
|
JP4694214B2
(ja)
*
|
2004-02-20 |
2011-06-08 |
ローム株式会社 |
比較器、ａｄ変換回路、半導体装置、および撮像装置
|
|
WO2005081866A2
(en)
|
2004-02-23 |
2005-09-09 |
Loma Linda University Medical Center |
Hemostatic agent for topical and internal use
|
|
US20070292502A1
(en)
*
|
2004-03-23 |
2007-12-20 |
Lytone Enterprise Inc. |
Chitosan-Embedded or Encapsulated Capsule
|
|
US7740883B2
(en)
*
|
2004-03-28 |
2010-06-22 |
University Of Debrecen |
Nanoparticles from chitosan
|
|
AU2005240189A1
(en)
*
|
2004-05-06 |
2005-11-17 |
Ivrea Pharmaceuticals, Inc. |
Particles for the delivery of active agents
|
|
WO2005112569A2
(en)
*
|
2004-05-13 |
2005-12-01 |
Medtronic Vascular, Inc. |
Methods for compounding and delivering a therapeutic agent to the adventitia of a vessel
|
|
GB0416328D0
(en)
*
|
2004-07-21 |
2004-08-25 |
Univ Cardiff |
Use of dry powder compositions for pulmonary delivery
|
|
US8673360B2
(en)
|
2004-08-10 |
2014-03-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Compositions that enable rapid-acting and highly absorptive intranasal administration
|
|
DE102004059792A1
(de)
|
2004-12-10 |
2006-06-14 |
Röhm GmbH & Co. KG |
Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
|
|
EP1824459A1
(en)
*
|
2004-12-17 |
2007-08-29 |
Medipol S.A. |
Hydrophilic particles based on cationic chitosan derivatives
|
|
US20090136505A1
(en)
|
2005-02-23 |
2009-05-28 |
Johanna Bentz |
Intranasal Administration of Active Agents to the Central Nervous System
|
|
US8303972B2
(en)
*
|
2005-04-19 |
2012-11-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
US9539410B2
(en)
|
2005-04-19 |
2017-01-10 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating post-cardial infarction damage
|
|
US20080125745A1
(en)
|
2005-04-19 |
2008-05-29 |
Shubhayu Basu |
Methods and compositions for treating post-cardial infarction damage
|
|
EP2974718A1
(en)
*
|
2005-04-29 |
2016-01-20 |
Cubist Pharmaceuticals, Inc. |
Therapeutic compositions
|
|
JP2007006849A
(ja)
*
|
2005-07-04 |
2007-01-18 |
Japan Science & Technology Agency |
６−アミノ−６−デオキシキトサン誘導体から成る核酸導入剤
|
|
US8846102B2
(en)
*
|
2006-03-30 |
2014-09-30 |
Engene, Inc. |
Non-viral compositions and methods for transfecting gut cells in vivo
|
|
US8119780B2
(en)
|
2006-06-02 |
2012-02-21 |
Synedgen, Inc. |
Chitosan-derivative compounds and methods of controlling microbial populations
|
|
AU2007262845B2
(en)
|
2006-06-20 |
2013-07-25 |
Mucovax Inc. |
Compositions comprising chitin microparticles and their medical uses
|
|
US20080248508A1
(en)
*
|
2006-08-17 |
2008-10-09 |
Shenda Baker |
Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
|
|
US9242005B1
(en)
|
2006-08-21 |
2016-01-26 |
Abbott Cardiovascular Systems Inc. |
Pro-healing agent formulation compositions, methods and treatments
|
|
US9005672B2
(en)
|
2006-11-17 |
2015-04-14 |
Abbott Cardiovascular Systems Inc. |
Methods of modifying myocardial infarction expansion
|
|
US8741326B2
(en)
*
|
2006-11-17 |
2014-06-03 |
Abbott Cardiovascular Systems Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
JP5415769B2
(ja)
*
|
2006-12-26 |
2014-02-12 |
株式会社新日本科学 |
経鼻投与用製剤
|
|
EP2112923A1
(en)
|
2007-01-22 |
2009-11-04 |
Targacept Inc. |
Intranasal, buccal, and sublingual administration of metanicotine analogs
|
|
GB0716907D0
(en)
*
|
2007-08-31 |
2007-10-10 |
Archimedes Dev Ltd |
Pharmaceutical powder compositions
|
|
GB0722507D0
(en)
*
|
2007-11-19 |
2007-12-27 |
Zhao Xiaobin |
Hyaluronic acid personal lubricant
|
|
DE102008059857A1
(de)
*
|
2008-12-01 |
2010-06-02 |
Forschungsinstitut für Leder und Kunststoffbahnen gGmbH |
Mit Kohlenhydrat-Derivaten additivierte Gelatinezusammensetzungen
|
|
US9101539B2
(en)
|
2009-05-15 |
2015-08-11 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal pharmaceutical compositions with improved pharmacokinetics
|
|
GB2472327B
(en)
|
2009-07-31 |
2013-03-13 |
Shin Nippon Biomedical Lab Ltd |
Intranasal granisetron and nasal applicator
|
|
EP2504039A4
(en)
|
2009-11-25 |
2014-07-02 |
Univ Loma Linda Med |
HEMOSTATIC TEXTILE BASED ON CHITOSAN
|
|
GB201006218D0
(en)
|
2010-04-14 |
2010-06-02 |
Ayanda As |
Composition
|
|
EP3178470A1
(en)
*
|
2011-04-11 |
2017-06-14 |
Vitux Group AS |
Oral pharmaceutical dispersion compositions
|
|
US8968790B2
(en)
*
|
2011-12-09 |
2015-03-03 |
Shaker A. Mousa |
Nanoformulation of vitamin D derivatives and/or vitamin D metabolites
|
|
FR2991172A1
(fr)
*
|
2012-06-01 |
2013-12-06 |
Galderma Res & Dev |
Compositions pharmaceutiques topiques comprenant des microcapsules
|
|
US9878000B2
(en)
|
2012-06-20 |
2018-01-30 |
University Of Waterloo |
Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
|
|
US20140005379A1
(en)
|
2012-06-20 |
2014-01-02 |
Frank GU |
Nanoparticle delivery system and components thereof
|
|
US9259357B2
(en)
|
2014-04-16 |
2016-02-16 |
Loma Linda University |
Composition, preparation, and use of chitosan shards for biomedical applications
|
|
US10182993B2
(en)
|
2015-04-06 |
2019-01-22 |
Patheon Softgels Inc. |
Compositions for colonic delivery of drugs
|
|
US12427224B1
(en)
*
|
2015-10-15 |
2025-09-30 |
Oceanit Laboratories, Inc. |
Hemostatic microparticles and dressing
|
|
CA3045043A1
(en)
|
2016-12-31 |
2018-07-05 |
Bioxcel Therapeutics, Inc. |
Use of sublingual dexmedetomidine for the treatment of agitation
|
|
US11744967B2
(en)
|
2017-09-26 |
2023-09-05 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal delivery devices
|
|
WO2019163520A1
(ja)
*
|
2018-02-26 |
2019-08-29 |
株式会社新日本科学 |
粉末製剤、カートリッジ、及びデバイス
|
|
CN115154440A
(zh)
|
2018-06-27 |
2022-10-11 |
比奥克斯塞尔医疗股份有限公司 |
含右美托咪定的膜制剂及其制造方法
|
|
NL2022788B1
(en)
*
|
2019-03-22 |
2020-09-28 |
No Ceuticals B V |
Chitosan nitrate for use as a nitric oxide donor (NO donor)
|
|
WO2021016112A2
(en)
|
2019-07-19 |
2021-01-28 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
|
CN112370437B
(zh)
*
|
2020-10-20 |
2022-10-21 |
好医生药业集团有限公司 |
一种阿莫西林胶囊及其制备方法
|
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
|
CN118304423B
(zh)
*
|
2023-05-25 |
2024-10-11 |
无锡市第二人民医院 |
多层级壳聚糖明胶颗粒载P4HA1 siRNA通过抑制细胞EMT治疗脑胶质瘤的研究
|